Full Text
Budget Impact Analysis of Dabrafenib and Trametinib Combination Therapy in The Treatment of Braf V600e-Mutant Advanced Non-Small Cell Lung Cancer in The United States

Abstract

Authors

Z Zhou A Bensimon J Cheng A Dalal

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×